What does CUSIP 676079106 represent in this 13F holders report?

CUSIP 676079106 is the security identifier for ODTC - ODONATE THERAPEUTICS INC - COM used to aggregate holder disclosures.

How many institutions held ODTC - ODONATE THERAPEUTICS INC - COM in Q4 2018?

52 institutional investors reported ODTC - ODONATE THERAPEUTICS INC - COM for Q4 2018. Use the holders table for investor-level position and value details.

ODONATE THERAPEUTICS INC - COM (ODTC)

CUSIP: 676079106

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class: Equity / COM
Total 13F shares: 24,631,869
Share change: -177,649
Total reported value: $346,815,577
Price per share: $14.08
Number of holders: 52
Value change: -$3,868,931
Number of buys: 25
Number of sells: 25

Quarterly Holders Quick Answers

What is CUSIP 676079106?
CUSIP 676079106 identifies ODTC - ODONATE THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2019
Previous quarter: Q3 2018

Recent filing periods for CUSIP 676079106:

Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021 Q4 2020 Q3 2020

Institutional Holders of ODONATE THERAPEUTICS INC - COM (ODTC) as of Q4 2018

As of 31 Dec 2018, ODONATE THERAPEUTICS INC - COM (ODTC) was held by 52 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,631,869 shares. The largest 10 holders included TANG CAPITAL MANAGEMENT LLC, BOXER CAPITAL, LLC, FRANKLIN RESOURCES INC, JANUS HENDERSON GROUP PLC, Samsara BioCapital, LLC, Redmile Group, LLC, Rock Springs Capital Management LP, FMR LLC, Invesco Ltd., and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 52 institutional shareholders reporting positions in this security for the Q4 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.